|

Heart Disease Clinical Trials in Alabama

75 recruiting studies across 14 cities

All Trials in Alabama

Phase
Trial Phase Location
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityPhase 3Alexander City
A Study of Modified Release RTN-001 In Patients With Uncontrolled HypertensionPhase 2Alexander City
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACSPhase 3Alexander City
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular InterventionPhase 4Alexander City
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular EventsPhase 3Alexander City
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial FibrillationPhase 3Alexander City
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionPhase 3Alexander City
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionPhase 3Alexander City
Forge AHEAD: Feasibility of Yoga to Improve Cognitive FunctionN/AAuburn
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular HypertrophyPhase 2Birmingham
A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA)Phase 1/2Birmingham
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)Phase 2Birmingham
A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava IsolationN/ABirmingham
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure PatientsPhase 3Birmingham
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes MedicationsPhase 3Birmingham
Abbott Cephea Mitral Valve Disease Registry—Birmingham
Abbott Vascular Medical Device Registry—Birmingham
Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPhase 3Birmingham
Assessment of CCM in HF With Higher Ejection FractionN/ABirmingham
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled StudyPhase 2/3Birmingham
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve DysfunctionN/ABirmingham
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)N/ABirmingham
Chronic Hypertension and Pregnancy 2 (CHAP2) Pilot ProjectPhase 1Birmingham
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial FibrillationN/ABirmingham
Community Health Worker Support to Lower Blood Pressure After a Pregnancy With High Blood PressureN/ABirmingham
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)N/ABirmingham
Cord Clamping Among Neonates With Congenital Heart DiseaseN/ABirmingham
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment—Birmingham
Impact of Bromocriptine on Clinical Outcomes for Peripartum CardiomyopathyPhase 4Birmingham
Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities—Birmingham
Inspire HER: Inspiring the Heart and Emotions for Radical HealthN/ABirmingham
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart FailureN/ABirmingham
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.Phase 2Birmingham
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery LesionsN/ABirmingham
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityPhase 3Birmingham
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease—Birmingham
PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosisPhase 3Birmingham
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)N/ABirmingham
Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight InfantsN/ABirmingham
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinPhase 3Birmingham
Prevail Global StudyN/ABirmingham
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products—Birmingham
Product Surveillance Registry—Birmingham
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE—Birmingham
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias—Birmingham
Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VTN/ABirmingham
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)Phase 3Birmingham
The Fourth Left Atrial Appendage Occlusion StudyN/ABirmingham
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.—Birmingham
The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) TrialPhase 4Birmingham
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.N/ABirmingham
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid RegurgitationN/ABirmingham
Valved Graft PMCF Study—Birmingham
Ventilator Pressure and Optimization of Compliance and HemodynamicsN/ABirmingham
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Phase 2/3Decatur
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery DiseasePhase 1Dothan
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With AnticoagulationPhase 2Dothan
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is UnsuitablePhase 3Dothan
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)Phase 3Fairhope
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor AntagonistsPhase 3Fairhope
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFPhase 3Fairhope
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEFPhase 2Fairhope
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM—Fairhope
Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRPPhase 2Fairhope
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve StenosisPhase 2Huntsville
A Phase 2b Clinical Trial of YN001 in Adults With Coronary AtherosclerosisPhase 2Huntsville
Diuretics vs. Afterload Reduction for Treatment of HeartLogic AlertsPhase 4Huntsville
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVRN/AHuntsville
Pivotal Study for the Cardiac Performance System (CPS)—Huntsville
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart FailureN/AHuntsville
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve ReplacementN/AHuntsville
Tracking Results of Ablations to Combat AF Registry Generation 2—Huntsville
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma—Mobile
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart FailurePhase 3Mobile
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart FailureN/AMobile

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.